Octane, Southern California's leading accelerator for technology and medical innovation, will host its Cardiovascular Tech Forum 2025 on September 11–12 at VEA Newport Beach, A Marriott Resort & Spa. The two-day forum will unite industry leaders, entrepreneurs, physicians, and investors to explore the future of cardiovascular innovation and shape the next generation of patient care.
The forum will feature a keynote address from Dr. John B. Simpson, PhD, MD, a pioneering interventional cardiologist and serial entrepreneur who invented the over-the-wire balloon angioplasty catheter, a groundbreaking advancement that transformed cardiovascular treatment. Dr. Simpson's participation underscores the event's focus on connecting medical innovation with practical clinical applications that can improve patient outcomes.
This gathering is significant because it facilitates collaboration between diverse stakeholders in the cardiovascular technology ecosystem. By bringing together physicians, entrepreneurs, and investors, the forum creates opportunities for developing new technologies that address critical unmet needs in cardiovascular care. The exchange of ideas and expertise at such events often leads to breakthroughs that can transform treatment protocols and improve survival rates for patients with heart disease.
The Cardiovascular Tech Forum represents an important convergence point for medical innovation, particularly as cardiovascular diseases remain the leading cause of death globally. Events like this accelerate the development and adoption of new technologies that can detect, monitor, and treat heart conditions more effectively. The participation of industry leaders and investors ensures that promising innovations receive the support needed to reach patients who could benefit from them.
For more information about the event, visit https://ibn.fm/BqI2u. The forum's focus on practical innovation and collaboration makes it an important catalyst for advancements in cardiovascular medicine that could benefit millions of patients worldwide.
